- Home
- Equipment
- asia middle east
- multiple myeloma
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Multiple Myeloma Equipment Supplied In Asia Middle East
7 equipment items found
Manufactured by:Antengene Corporation Limited based inChangning District, CHINA
Multiple myeloma is caused by the dysregulated proliferation of plasma cells, characterized by the proliferation of monoclonal plasma cells that results in an overabundance of monoclonal immunoglobulin or its fragment (M protein). Clinical manifestations of MM include hypercalcemia, renal insufficiency, anemia, and the destruction of the bone. 1,2 MM primarily ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph ...
Manufactured by:Hunan Huateng Pharmaceutical Co. Ltd. based inChangsha City, CHINA
1-Pentanone,2-amino-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-,(2S)-,2,2,2-trifluoroacetate(1:1). Huateng Pharmaceutical, a global supplier of API intermediates, offers Carfilzomib intermediate (2S)-2-AMino-4-Methyl-1-[(2R)-2-Methyloxiranyl]-1-pentanone trifluoroacetate (CAS No.: 247068-85-5) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package ...
Manufactured by:Hunan Huateng Pharmaceutical Co. Ltd. based inChangsha City, CHINA
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate. Huateng Pharmaceutical, a global supplier of Pharmaceutical intermediates, offers Carfilzomib intermediate Boc-HPh-Leu-Phe-Ome (CAS No.: 868539-96-2) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for ...
Manufactured by:JW Pharmaceutical Corporation based inSeocho-gu, SOUTH KOREA
Active Ingredients: cyclophosphamide 50mg per 1 ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our pluripotent cell technology using a directed differentiation method, is comprised of a population of mature dendritic cells. As the most potent type ...
Manufactured by:RedHill Biopharma Ltd. based inTel-Aviv, ISRAEL
Opaganib (ABC294640) is a first-in-class, proprietary sphingosine kinase-2 (SK2) selective inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral ...